Isomorphic Labs in early talks to raise at $40B+ valuation, Bloomberg reports
nmasc_ · x · 2026-10-08
Isomorphic Labs, the AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funding at a valuation of at least $40B, Bloomberg reports. Led by DeepMind founder Demis Hassabis, the company applies AI to accelerate drug discovery, and the reported valuation underscores surging investor appetite for AI-for-science plays.
Related event: Isomorphic Labs in Talks for Funding at Valuation Up to $50 Billion(6 posts)→
More from Venture
- One viral tweet can kick off a multi-million dollar fundraise, says VC-watching founder — zebird0 · 2026-10-08
- Verso raises $6M to bring consumer intelligence into business decisions — clemnt · 2026-10-08
- Six years on, A100 still leads Nvidia chip mentions in AI papers — ahead of H100+H200 — nathanbenaich · 2026-10-08
- OpenAI+Anthropic run rates hit ~$105B as US pivots to 'superintelligence' — nathanbenaich · 2026-10-08
- 20VC: OpenAI nears $70B run rate, ElevenLabs doubles to $22B, Salesforce buys Listen Labs for $2B — 20VC · 2026-10-08
- Walking app with 500K downloads and ~$20K/mo, a full growth breakdown — victor_explore · 2026-10-08